CD274 and neoplasm: Importantly, our data demonstrate that MMW monotherapy exhibits significant anti-tumor efficacy and immune remodeling capabilities in “cold tumor” models (4T1 and CT26), surpassing the response observed with α-PD-L1 monotherapy in these settings.